Defender Capital, LLC. - Q1 2022 holdings

$288 Million is the total value of Defender Capital, LLC.'s 36 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 15.4% .

 Value Shares↓ Weighting
VGSH BuyVANGUARD SHORT TERM TREASURYetf$45,763,000
+5.4%
772,246
+8.2%
15.92%
+14.4%
STAA BuySTAAR SURGICAL CO$31,062,000
+27.0%
387,857
+44.8%
10.80%
+37.8%
FTV BuyFORTIVE CORPORATION$28,439,000
-17.4%
460,616
+2.1%
9.89%
-10.4%
AXON BuyAXON ENTERPRISE INC$15,022,000
-7.6%
107,810
+4.1%
5.22%
+0.2%
TDY BuyTELEDYNE TECHNOLOGIE$13,393,000
+90.5%
28,480
+130.6%
4.66%
+106.7%
CFX BuyCOLFAX CORPORATION$8,902,000
-10.1%
220,616
+2.4%
3.10%
-2.4%
LCTX BuyLINEAGE CELL THERAPEUTIC$7,983,000
-34.8%
5,006,185
+0.2%
2.78%
-29.3%
INTC BuyINTEL CORP$7,718,000
-2.5%
154,565
+0.6%
2.68%
+5.8%
OCX BuyONCOCYTE CORP$4,001,000
-16.8%
2,562,130
+15.6%
1.39%
-9.8%
BE BuyBLOOM ENERGY CORP$3,603,000
+720.7%
151,000
+655.0%
1.25%
+788.7%
PLTR BuyPALANTIR TECHNOLOGIES$2,169,000
-2.6%
153,065
+25.1%
0.75%
+5.6%
ANIP BuyANI PHARMACEUTICALS$675,000
-22.9%
24,000
+26.3%
0.24%
-16.4%
MSFT BuyMICROSOFT CORP$643,000
-7.5%
2,085
+1.0%
0.22%
+0.4%
IWM NewISHARES RUSSELL 2000etf$411,0002,000
+100.0%
0.14%
WFC NewWELLS FARGO$246,0005,074
+100.0%
0.09%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2022-06-07
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BERKSHIRE HATHAWAY INC DEL CL B20Q3 202324.4%
DANAHER CORPORATION COM20Q3 202318.3%
STAAR SURGICAL CORPORATION20Q3 202320.2%
FORTIVE CORPORATION20Q3 202314.3%
MONSTER BEVERAGE CORPORATION20Q3 202317.3%
APPLE INC20Q3 20230.6%
AMAZON INC COM20Q3 20230.4%
VANGUARD SHORT TERM TREASURY ETF IV17Q3 202323.9%
LINEAGE CELL THERAPEUTICS INC17Q3 20234.8%
COMPUGEN LTD ORD17Q1 20231.9%

View Defender Capital, LLC.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-06
13F-HR2024-01-23
13F-HR2023-10-23
13F-HR2023-07-18
13F-HR/A2023-05-16
13F-HR2023-04-27
13F-HR2023-01-12
13F-HR2022-10-18
13F-HR2022-07-26
13F-HR/A2022-06-07

View Defender Capital, LLC.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Defender Capital, LLC.'s holdings